Wei-Sheng Huang Selected Research

Wei-Sheng Huang Research Topics

5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2011 - 08/2009
4	Neoplasms (Cancer) 11/2016 - 08/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2016
1	Major Depressive Disorder (Major Depressive Disorders) 01/2018
1	Disease Progression 11/2016
1	Lung Neoplasms (Lung Cancer) 11/2016
1	Lymphoma (Lymphomas) 01/2016
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2016

3	Phosphotransferases (Kinase)IBA 01/2016 - 11/2009
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 11/2016
2	brigatinibIBA 11/2016 - 01/2016
2	Anaplastic Lymphoma KinaseIBA 11/2016 - 01/2016
2	Imatinib Mesylate (Gleevec)FDA Link 01/2011 - 11/2009
1	mobocertinibIBA 01/2021
1	Proton Pump InhibitorsIBA 01/2018
1	CrizotinibIBA 11/2016
1	EnzymesIBA 01/2016
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2016
1	Adenosine Triphosphate (ATP)IBA 02/2013
1	Lactate Dehydrogenase 5IBA 02/2013
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2010
1	ponatinibIBA 11/2009
1	nilotinib FDA Link 11/2009
1	Dasatinib (BMS 354825)FDA Link 11/2009
1	AP 24163IBA 08/2009

2	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 01/2022 - 01/2020
2	Therapeutics 11/2009 - 08/2009
1	Diabetic Diet 01/2020
1	Communication Aids for Disabled (TDD) 01/2020
1	Oral Administration 08/2009